- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Jeffrey M. Telep (Jeff)
Events 12 results
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Webinar
January 18, 2023
California MCLE Institute
Conference
November 8, 2022
American-Danish Business Council CEO Roundtable
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Conference
June 9, 2016
King & Spalding Fifth Annual Patent Law Seminar
Conference
May 18, 2016
Tech Law Talks
Webinar
March 10, 2016
King & Spalding e-Learn: TPP: Prospects For Implementation And What TPP Means For Life Sciences Companies
Webinar
August 26, 2015
Combatting Unfair Intellectual Property Practices In International Trade In The Pharmaceutical Industry
Webinar
June 29, 2015
Is International Trade Secret Protection Readily Ascertainable? A Discussion of Issues Related to International
Conference
May 6, 2015
King & Spalding Patent Seminar: A Summary of Recent Developments
Webinar
April 21, 2015
Interplay Between Parallel ITC, USPTO And District Court Proceedings